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1. Introduction 
Cardiac resynchronization therapy (CRT) is a therapeutic option for heart failure patients 
with a severely reduced left ventricular ejection fraction and left bundle branch block 
(Cleland et al., 2001). Ventricular resynchronization is achieved by biventricular pacing, 
usually via electrodes in the right ventricular apex and a left ventricular (LV) electrode 
positioned in a coronary vein. 
About one third of implanted patients do not respond to CRT (Derval et al., 2010). In order 
to reduce the percentage of non-responders, several strategies have been developed. They 
include optimization of patient selection, device programming as well as LV lead location. 
In cardiomyopathy with left bundle branch block, the lateral wall is the site of latest 
activation and should be the optimal location for LV pacing. Therefore, standard 
implantation sites for LV leads are lateral or posterolateral branches of the coronary sinus. 
Congruent to these pathophysiological findings, Butter et al. demonstrated a superiority of 
lateral wall pacing versus anterior wall pacing in CRT (Butter et al., 2001). However, a more 
detailed look at optimal pacing locations might be required to increase the effect of CRT and 
decrease non-responder rates.  
Different imaging modalities have been used to both identify optimal pacing sites as well as 
to plan LV lead implantation.  
2. Imaging for cardiac resynchronization therapy 
Imaging for CRT is focused on imaging of the coronary venous (CS) system for CS lead 
implantation and on imaging techniques to asses the left ventricular function for patient 
selection, choose the optimal lead position and to evaluate the effect of CRT. 
Contrast angiography is commonly used for imaging of the coronary venous system. To 
evaluate ventricular function including dyssynchrony, transthoracic echocardiography is 
commonly applied as it is widely availably and inexpensive. A lot of efforts have been done 
to improve patient selection by echoardiographic screening and there are hundreds of 
papers published on echocardiographic evaluation of mechanical dyssynchrony, including 
the use of tissue Doppler imaging, speckle tracking, three-dimensional and contrast 
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echocardiography. However, in the PROSPECT trial with almost 500 patients no single 
echocardiographic parameter could predict response with convincing sensitivity and 
specificity (Chung et al., 2008). Despite good results in single-center studies, 
echocardiography for assessment of dyssynchrony is limited by high intra- and inter-
observer variability, measurement errors and in some patients low image quality. 
Alternatives to echocardiography include magnetic resonance imaging, computed 
tomography and nuclear imaging. Magnetic resonance imaging has the benefit of high 
spatial resolution, high reproducibility and information on viability. A high scar burden and 
pacing over a posterolateral scar are associated with poor response to CRT (Bleeker et al., 
2006, White et al., 2006). Whereas magnetic resonance imaging is the gold standard to assess 
myocardial viability, computed tomography also provides information on scar burden and 
localization as well as left ventricular function and dyssynchrony. However, data on 
dyssynchrony measured by computed tomography are limited and there are no published 
data for the prediction of CRT response. In addition, computed tomography is associated 
with radiation exposure. Nuclear imaging with single photon computed tomography and 
positron emission tomography is also associated with radiation exposure. Nuclear imaging 
provides information on scar burden and scar localization, ventricular function and 
dyssynchrony. However, a major disadvantage of nuclear imaging is the low spatial 
resoluation. 
2.1 Imaging of the coronary venous system 
Left ventricular leads are usually implanted in a lateral or posterolateral branch of the 
coronary sinus. Contrast venography is a standard procedure performed either before or 
during implantation to identify suitable target veins. Table 1 displays imaging modalities for 
the coronary venous system. 
 
 Advantages Disadvantages Clinical relevance 
Retrograde contrast 
CS angiography  
Good vessel visibility 
Can be performed during 
CRT implantation  
invasive 
standard 
procedure 
Rotational CS 
angiography 
3D imaging 
Can be performed during 
CRT implantation 
invasive limited experience  
Computed 
tomography  
Non-invasive 
radiation 
exposure 
limited experience 
MRI 
Non-invasive 
No radiation exposure  
lower spatial 
resolution 
limited experience 
Venous phase CS 
angiography  
Can be performed during 
standard coronary 
angiography 
lower vessel 
visibility 
limited experience 
Table 1. Imaging modalities for the coronary venous system 
Because a lot of patients with heart failure undergo a coronary angiogram, we compared 
retrograde occlusion venography with venous phase imaging of the coronary sinus in 24 
patients (Mischke et al., 2007). 
www.intechopen.com
 Cardiac Resynchronization Therapy: Lead Positioning and Technical Advances 
 
99 
 
Fig. 1. Venous phase coronary sinus angiography (left anterior oblique projection). 
 
 
Fig. 2. Retrograde coronary sinus angiography (left anterior oblique projection). 
Suitable target vessels for LV lead implantation were identified in all patients by both 
imaging modalities. Although visibility was superior in retrograde venography than in 
venous phase imaging, this technique might be an alternative to retrograde venography in 
patients undergoing a coronary angiogram. Venous phase angiography is time-saving and 
easy to perform. Figures 1 and 2 display a venous phase coronary sinus angiography and a 
retrograde occlusion venography. 
Some of the standard C-arms used for fluoroscopy allow rotational angiography with a 3D 
image. In an animal model we compared rotational coronary sinus angiography to ECG-
gated enhanced cardiac dual source computed tomography (Knackstedt et al., 2008a). We 
found no significant difference between these imaging modalities with respect to vessel 
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diameters or vessel visibility. In contrast to computed tomography, rotational angiography 
images can be obtained within seconds in the catheter lab without a time lag between 
cardiac imaging and procedure. In addition, estimated radiation exposure and the amount 
of contrast medium were lower in rotational coronary sinus angiography.  
We compared retrograde coronary sinus angiography with multi-slice computed 
tomography for visualization of the coronary venous system in 20 patients with congestive 
heart failure (Knackstedt et al., 2008b). Vessel visualization was better using retrograde 
coronary sinus angiography except for the middle cardiac vein and small veins, which were 
better seen with computed tomography. There was a trend that computed tomography 
detected more vessels. Overall, retrograde coronary sinus angiography offered a better 
display of target vessels commonly used for LV lead implantation. 
Imaging of the coronary sinus via cardiac computed tomography correlates well with direct 
coronary sinus venography (Van de Verie et al., 2006). Imaging of the coronary venous 
anatomy by computed tomography is non-invasive and can help to plan coronary sinus lead 
implantation especially in patients with angulated coronary veins and in patients in whom a 
left marginal vein or a posterior vein is absent. It also provides information on the 
localization of the left phrenic nerve in relation to the target vein. However, it is associated 
with radiation and contrast agent exposure. 
Magnetic resonance imaging of the coronary venous anatomy allows adequate assessment of 
localization, size and angulations of the veins (Ma et al., 2010; Nezafat et al., 2007). However, 
spatial resolution is inferior to computed tomography and magnetic resonance imaging cannot 
routinely be performed in patients with cardiac implants, e.g. patients scheduled for an 
upgrade from an implantable cardioverter defibrillator (ICD) to a CRT device. 
2.2 Magnetic resonance imaging in CRT patients 
Implanted devices like pacemakers and ICDs generally pose a contraindication to magnetic 
resonance imaging. However, magnetic resonance imaging might be performed with only 
small risks for the patient and device. In order to reduce the risks, careful patient selection, 
constant monitoring, specific absorption rate management and careful device programming 
before the scan have been used in the past. In a recent study Wilkoff et al. evaluated the safety 
of a pacemaker especially designed for safe magnetic resonance imaging (Wilkoff et al., 2011). 
Several modifications were used to improve the safety of magnetic resonance imaging, 
including modification of the leads to reduce lead tip heating, reduction of the amount of 
ferromagnetic materials, replacement of the reed switch by a Hall sensor, whose behaviour in 
a static magnetic field is predictable. In this prospective randomized study magnetic resonance 
imaging with a 1.5 T scanner could be performed without adverse events. 
3. Left ventricular lead implantation 
Cardiac resynchronization requires left ventricular pacing. The standard approach for left 
ventricular lead implantation is a transvenous implantation into a lateral or posterolateral 
tributary of the coronary sinus. Although dedicated instruments allow successful LV lead 
implantation in most patients, failure rates of 5-17% have been reported (Abraham et al., 
2002; Al-Khadra et al., 2005; Purerfellner et al., 2000). In these patients, LV leads are usually 
implanted onto the LV epicardium through thoracotomy or thoracoscopy. In addition, there 
are several alternatives to standard LV lead implantation techniques, including endocardial 
LV lead implantation, LV lead implantation assisted by magnetic navigation and video-
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assisted pericardioscopic epicardial LV lead implantation. As the access to LV regions is 
limited by the anatomy of the venous coronary system in standard procedures with 
transvenous CS lead implantation, some strategies aim at improved access to LV regions: 
- Epicardial stimulation 
- Endocardial LV stimulation 
- Magnetic navigation for CS lead implantation 
- Microcatheter LV stimulation 
Table 2 lists advantages und risks of LV lead implantation techniques. 
 
 Advantages Disadvantages Clinical relevance 
Standard 
transvenous 
implantation into  
CS tributary  
Low 
periprocedural risk 
 
Limited access to 
LV regions 
Risk of dislocation 
Failure in 5-17% 
Standard 
implantation 
procedure 
Epicardial 
implantation via 
thoracotomy or 
thoracoscopy 
Access to all LV 
regions 
Surgical risks 
First-line alternative 
to transvenous LV 
lead implantatoin 
Endocardial LV 
lead implantation 
Access to all LV 
regions 
Fast impulse 
propagation 
Risk of 
thromboembolism 
limited experience 
with patients 
Magnetically 
navigated CS lead 
implantation 
Possibly improved 
access to target 
vessels 
 
Experimental/limited 
experience with 
patients 
Video-assisted 
pericardioscopic 
epicardial 
implantation 
Access to all LV 
regions 
 Experimental 
Table 2. LV lead implantation techniques 
3.1 Alternatives to right ventricular pacing 
Whereas right ventricular apical pacing is the standard for patients requiring a pacemaker, 
this mode of stimulation is associated with electromechanical dyssynchrony and may 
contribute to worsening of the cardiac function (Tantengco et al., 2001). Because of the 
detrimental effects of right ventricular apical pacing several strategies have been suggested 
to avoid or reduce right ventricular apical pacing, including biventricular pacing either by 
de novo implantation of a CRT device or by upgrading an existing pacemaker, changes in 
programming to reduce the percentage of right ventricular pacing and alternative pacing 
sites. Careful patient selection and minimal ventricular pacing algorithms can substantially 
reduce the amount of right ventricular pacing and have been implemented into clinical 
practice (Tops et al., 2009). Several studies have demonstrated a hemodynamic and 
symptomatic benefit of upgrading right ventricular apical pacing to CRT as well as CRT in 
patient with indications for permanent pacing (Tops et al, 2009). However, so far it remains 
uncertain whether this will translate into a prognostic benefit. Alternative pacing sites have 
been suggested to avoid right ventricular apical pacing, including pacing the right 
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ventricular outflow tract, septal pacing and direct His bundle pacing. A meta-analysis by de 
Cock (de Cock et al., 2003) showed a favorable hemodynamic effect, and a study by Venerio 
(Vanerio et al., 2008) demonstrated an improved survival in patients with right ventricular 
outflow tract pacing as compared to right ventricular apical pacing. However, most studies 
include rather small numbers of patients and are of short follow up, so more data are 
needed to evaluate the relevance of right ventricular outflow tract pacing for clinical routine. 
Septal pacing has been shown to decrease ventricular dyssynchrony compared to right 
ventricular apical pacing (Yu et al., 2007) but there was no difference in left ventricular 
ejection fraction in a  prospective study by Kypta (Kypta et al., 2008). Direct His-bundle 
pacing or para-Hisian pacing allows a more physiological impulse propagation than right 
ventricular apical pacing but is associated with difficulties in lead positioning and concerns 
about pacing thresholds (Tops et al., 2009).  
Henz (Henz et al., 2009) demonstrated in a small animal study the feasibility of 
atrioventricular septal synchronous pacing with intramyocardial leads implanted deep within 
the atrioventricular septum; further animal studies are needed to evaluate this approach. 
3.2 Optimized CS lead implantation 
Already a decade ago Butter et al. demonstrated a hemodynamic superiority of pacing from 
a lateral vein compared to an anterior vein for CRT (Butter et al., 2001). The distance 
between stimulation site and the region of latest contraction may be crucial for 
hemodynamic benefit of CRT (Ypenburg et al., 2008). This is in line with findings from 
animal studies (Helm et al., 2007) and studies using echocardiographic parameters in 
patients (Becker et al., 2007a and 2007b). 
We used computed tomography and MRI imaging prior to LV lead implantation in 20 
patients with congestive heart failure (Knackstedt et al., 2010a). Computed tomography was 
used for imaging of the coronary venous system and MRI to detect the region of latest 
contraction. Computed tomography and MRI images were then over-imposed to determine 
a coronary side branch suitable for lead implantation that is closest to the region of latest 
contraction. There was a trend towards a shorter distance between the LV lead and the 
region of latest contraction in patients classified as responders. 
Another approach is the use of myocardial deformation analysis assessed by circumferential 
strain analysis during echocardiography to determine the optimal site for CS lead 
implantation. In a study with 56 patients optimal LV lead position was defined as a lead 
position close to the segment with latest systolic strain prior to CRT (Becker et al., 2010). 
During follow up, patients with leads implanted in an “optimal position” experienced a 
significantly higher increase in left ventricular ejection fraction than patients with leads 
implanted at other sites. 
In a smaller study Ducket et al. performed computed tomography and MRI to acquire 3D 
whole heart images. After segmentation, 3D anatomical models were overlaid over live 
fluoroscopy to guide LV lead implantation (Ducket et al., 2010).  
3.3 Endocardial LV lead implantation 
Endocardial lead implantation is associated with a high risk of systemic thromboembolism 
(van Gelder et al., 2000). However, endocardial LV lead implantation has several (potential) 
advantages to CS and epicardial LV leads: it allows access to all LV regions, endocardial 
ventricular layers offer faster impulse propagation than epicardial leyers and endocardial 
stimulation might result in improved hemodynamics. Van Deursen demonstrated in an 
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acute canine model a superior electrical resynchronization as well as +dP/dT(max) when 
endocardial biventricular stimulation was used instead of epicardial stimulation. In 
addition, whereas epicardial stimulation resulted in a transmural dispersion of 
repolarization, this was not observed in endocardial stimulation (van Deursen et al., 2009).  
However, Spragg et al. compared the hemodynamic effects of endocardial pacing at sites 
directly transmural to the CS lead tip in a small study of patients and found no difference in 
hemodynamics (Spragg et al., 2010). In this study a superior hemodynamic result was seen 
in 8 of 11 patients when endocardial pacing was performed from extreme basal sites at 
positions adjacent to the mitral ring. In a study by Derval et al. (Derval et al., 2010) pacing at 
the best LV site in 35 patients with non-ischemic dilated cardiomyopathy was associated 
with twice the improvement in +dP/dT(max) compared to CS pacing. 
In summary, the major benefit of endocardial left ventricular pacing seems to be the access 
to all LV regions, whereas endocardial stimulation per se seems to be only of minor 
relevance.  
In a few patients with major surgical contraindications to epicardial LV leads have been 
implanted through a transseptal approach (Jaïs et al., 2000; Leclercq et al., 1999; van Gelder 
et al., 2007). However, this approach is technically challenging. In addition to the risk of 
thromboembolism due to leads in the LV cavity, the adjacency to the mitral valve carries the 
risk of mitral insufficiency as well as endocarditis in case of infectious complications. A 
transapical approach which has been described by Kassai et al. in a limited number of 
patients would avoid passage of the mitral valve (Kassai et al., 2008). 
3.4 Magnetically navigated LV lead implantation 
A tortuous course of the coronary venous tree and target veins with small diameters can 
sometimes be challenging for CS lead implantation. New wire and lead navigation systems 
might facilitate lead implantation. The Niobe System (Stereotaxis Inc., St. Louis, USA) 
allows remote magnet controlled navigation of catheters and guidewires. The magnetically 
navigation system consists of two permanent magnets creating a steerable magnetic field 
(figure 3). The magnetic guidewires include a small magnet at their tip and can be steered 
by changing the orientation of the outer magnets. The magnetic field vector is displayed on 
a monitor and can be changed from the control room or from a bedside touch-screen 
monitor with sterile covers (figure 4). 
We studied 123 patients who were assigned to either conventional CS lead implantation or 
LV lead implantation using magnetic navigation (Mischke et al., 2009). Venography of the 
coronary venous system was performed to select a target vessel for lead implantation. Left 
ventricular lead placement was analyzed with regard to three endpoints: 1) engagement of 
the target vessel with the guidewire, 2) over-the-wire lead placement in the target vessel, 
and 3) final LV lead position. Guidewire access to the target vessel was achieved in all 
patients using magnetic navigation compared to 87% with the conventional approach 
(p<0.05). Implantation success rates, total procedure and fluoroscopy times did not differ 
significantly between groups. Gallagher et al. used the Niobe system for CRT implantation 
in 50 patients (Gallagher et al., 2007). In this study, vessels were engaged either by CS 
venography and the use of a magnetic guidewire or via a “bare wire” approach without 
venography or special CS delivery sheaths. For the “bare wire” approach, the guidewire 
was used to probe for a target vessel as a substitute for CS venography. This was associated 
with a reduction in procedure and fluoroscopy time compared to the use of CS sheaths and 
venography. 
www.intechopen.com
 Cardiac Pacemakers – Biological Aspects, Clinical Applications and Possible Complications 
 
104 
 
Fig. 3. Catheter suite with a magnetic navigation system (Niobe). Permanent magnets to both 
sides of the fluoroscopy table can be moved inside their casings to alter the magnetic field. 
Magnetic navigation might be used as an additional tool for precise wire navigation and 
enable the operator to engage target vessels that are tortuous. In addition, technical 
advances in lead design might allow engagement of vessels which are now being considered 
inadequate due to morphology or size. We have recently demonstrated the feasibility of left 
ventricular stimulation via a miniaturized magnetized stimulation wire in an acute animal 
model (Knackstedt et al., 2010b). A conventional guide wire with a permanent magnet and a 
single stimulation electrode at its tip was coated with iridium oxide at the distal end and 
insulated except for the very tip. The stimulation wire was steered into side branches of the 
coronary sinus via magnetic navigation and successful left ventricular stimulation was 
performed via the wire. 
 
 
Fig. 4. Navigant screenshot. Two x-ray images have been transferred to the navigation 
software and tributaries of the CS have been marked with colors. The red arrow indicates 
the direction of the magnetic field vector. 
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3.5 Video-assisted pericardioscopic epicardial lead implantation 
In an animal study we used flexible and rigid endoscopy for implantation of epicardial 
pacing leads via a subxiphoidal access (Hatam et al., 2010). Rigid endoscopy showed to be 
superior to flexible endoscopy with regard to stability and orientation within the pericardial 
space, and leads were successfully implanted onto all four cardiac chambers. This minimally 
invasive procedure allows access to all left ventricular regions. However, this technique 
requires a subxiphoidal access to the epicardial space and the endoscopy is associated with 
ventricular arrhythmias. 
3.6 Leadless pacing 
Pacing without pacemaker leads would decrease the risk of infection and might allow 
multisite pacing and thus decrease dyssynchrony. Ultrasound and magnetic field waves 
have been used to induce electrical stimulation via an intracardiac receiver electrode (Kapa 
et al., 2010; Lee et al., 2007). In an animal study Echt et al. (Echt et al., 2006) used burst 
ultrasound energy transmission through the chest to a  receiver electrode mounted on a 
catheter that converted the ultrasound energy to electrical energy sufficient to pace the 
myocardium. Biventricular pacing was also possible in this acute animal study. Microscopic 
evaluation revealed no evidence of mechanical or thermal bioeffects. Lee et al. successfully 
tested this system in patients undergoing electrophysiological studies (Lee et al., 2006). The 
technology in this study is under development as a leadless implantable system for chronic 
use. Technical challenges include a high beat-to-beat variation in the receiver electrode 
output as well as inefficient energy conversion: less than 1% of the transmitted energy was 
used for cardiac pacing. 
In an acute animal study Wieneke (Wieneke et al., 2009) demonstrated the feasibility of 
cardiac pacing via induction technology. The systems consisted of a transcutaneously 
implanted transmitter unit made of a ring-shaped copper coil and a receiver unit implanted 
in the right ventricular apex. The transmitter generated an alternating magnetic field of 
around 0.5 mT that was converted into a voltage pulse by the receiver in order to pace the 
ventricle. So far results have been published from one pig only, and no data on chronic 
pacing are availably. 
A promising miniaturized leadless pacemaker is being developed by Medtronic 
(Minneapolis, USA): the small device can be deployed with a catheter from a venous access 
and implanted into the ventricular cavity. Up to now no animal or human data have been 
published about the device. 
4. Electrical remodeling in CRT 
In congestive heart failure (CHF), a complete left bundle branch block causes asynchronous 
ventricular contraction due to regional dispersion of ventricular depolarization, resulting in 
intra- and interventricular mechanical asynchrony. CRT reduces the heterogeneity of 
ventricular contraction by biventricular stimulation.  
Especially patients with a very broad QRS-complex (> 150 msec) seem to profit most from 
CRT (Chung et al., 2008; Moss et al., 2009). Although QRS duration is not an optimal 
criterion for selecting patients amenable for CRT and some studies have failed to predict 
clinical and echocardiographic response to CRT, it remains an important criterion for 
dyssynchrony for the indication of CRT (Boriani et al., 2006; Gervais et al., 2009; Hawkins et 
al., 2006; Mollema et al., 2007). 
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In CRT, biventricular stimulation usually results in a narrowing of the stimulated QRS-
complex and a reduction in left ventricular chamber size as well as improvement in ejection 
fraction. The extent of the QRS shortening induced by biventricular pacing seems to 
correlate with the structural remodeling (Boriani et al., 2006; Kronborg et al., 2010). 
However, about one third of patients fail to respond to CRT (Cleland et al., 2001; Chung et 
al., 2008; Lafitte et al., 2009). A lot of effort has been spent to both identify patients who are 
likely to benefit from CRT and to increase the benefit from CRT, e.g. by optimizing AV and 
VV delays (Strauss et al., 2010). 
Although CRT has been shown to induce a structural remodeling resulting in reduction in 
left ventricular dimensions and improvement in ejection fraction, there is scarce and 
controversial data on a possible remodeling of the native conduction system (Dizon et al., 
2004; Henrikson et al., 2007; Stockburger et al., 2008). 
We studied the effect of CRT on the native conduction system in a small prospective study 
(Mischke et al., 2011). A CRT device was implanted in 38 patients with congestive heart 
failure (ejection fraction (EF): 26 ± 7%). 20 patients suffered from dilated cardiomyopathy 
and 18 from ischemic cardiomyopathy. Standard 12-lead ECGs with and without pacing as 
well as echocardiographies were obtained prior to implantation and after 6 and 12 months. 
Patients were classified as responders in case of an increase in EF ≥ 25% in combination with 
an increase in NYHA class ≥ 1. The EF increased to 36 ± 10% (p<0.0001) after 6 months and 
40 ± 12% (p<0.0001) after 12 months of CRT. Intrinsic QRS duration decreased from 171 ± 18 
ms before CRT to 164 ± 23 ms (p=0.027) after 6 months and 161 ± 25 ms (p=0.002) after 12 
months of CRT (figure 5). 22 patients (58%) were classified as responders. Whereas a 
significant decrease in intrinsic QRS duration was observed in responders, only a slight 
decrease was seen in non-responders. However, two-factorial variance analyses did not 
show a significant influence of response or underlying heart disease (dilated or ischemic 
cardiomyopathy) on the change in QRS duration (p=0.7).  
 
 
Fig. 5. Baseline and intrinsic QRS duration (from Mischke et al., 2011) 
This was the first prospective study to demonstrate a decrease in intrinsic QRS duration in 
patients treated with CRT. Dizon et al. reported the first case of loss of bundle branch block 
in a patient 6 months after implantation of a CRT device (Dizon et al., 2004). However, data 
on intrinsic QRS duration is controversial. No change in intrinsic QRS duration was seen in 
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the MUSTIC trial as well as in a study by Stockburger (Stockburger et al., 2008). Two studies 
displayed a trend towards a reduction in intrinsic QRS duration (Boriani et al., 2006; Vogt et 
al., 2000). Similar to our results, a retrospective study by Henrikson et al. showed a 
significant reduction in intrinsic QRS duration after 14 months of CRT in 25 patients 
(Henrikson et al., 2007). Experimental data suggest a subcellular redistribution of 
connexin43 and ion channel remodeling with a reduction in inward rectifier K+ current, 
delayed rectifier K+ current and transient outward K+ current) and abnormal Ca2+ 
homeostasis in left bundle branch block (Aiba et al., 2009; Spragg et al., 2005). CRT partially 
restored this ion channel remodeling and attenuated the regional heterogeneity of action 
potential duration. Although human data on intrinsic QRS duration in CRT is controversial, 
an impact on the conduction system by several factors including connexin redistribution 
and reduction in left ventricular dimensions is quite conceivable. 
5. Conclusion 
Cardiac resynchronization therapy is an effective treatment for patients with congestive 
heart failure and complete left bundle branch block. However, about one third of all patients 
who undergo CRT do not profit from it. Several strategies have been tried to reduce the 
percentage of non-responders, including optimized patient selection, device programming 
and optimized positioning of the left ventricular lead. However, due to high interpatient 
variability there seems to be no single best pacing site for all patients. Acute hemodynamic 
testing during implantation is time-consuming and good acute effects might not translate 
into a long-term clinical benefit.  
None of these approaches has had a relevant impact on daily practice yet. In order to have 
the maximum benefit for our patients, we need to individualize the approach to CRT. 
Technical advances, like new lead designs and guiding catheters, are crucial for the further 
progress in CRT. 
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